MARA BASED INDUSTRIAL LOW COST IDENTIFICATION ASSAYS
The fast and cost-efficient detection of pathogens is highly important in many sectors such as healthcare, agriculture, and food industry. However, current technologies are limited, and significant advances are required to develop...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
LoveFood2Market
A portable MicroNanoBioSystem and Instrument for ultra fast...
3M€
Cerrado
AMP-FWBD
Advanced Molecular Platform for detection of Food and Water...
185K€
Cerrado
AGL2017-86797-C2-1-R
VIRUS, BACTERIAS Y PROTOZOOS DE INTERES EN SEGURIDAD ALIMENT...
236K€
Cerrado
NELLAFLOW
New generation of low cost Lateral Flow Assays LFAs couple...
319K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The fast and cost-efficient detection of pathogens is highly important in many sectors such as healthcare, agriculture, and food industry. However, current technologies are limited, and significant advances are required to develop low-cost (<10€) detection assays that can detect a few bacterial cells (<10 cells/ml) within less than one hour. In the FET-Open project MARA, which is the basis for MARILIA, we have developed novel technologies and tools that have a high exploitation potential. Thus, we have initiated the follow-up project MARILIA, which aims to exploit these results and realise a new detection concept for the fast, low-cost identification of human pathogens in water samples. In MARILIA, we will increase the technology readiness level (TRL) of our novel detection concept from TRL 2 to TRL 5. A well-balanced consortium has been established, comprising an applied research institute as coordinator (AIT, coordinated also the MARA project), a university (UZ), a basic research institute (RBI), an SME (D1, acting as business incubator) and a large company (IREN, representing a potential future customer). If the MARILIA detection assay meets the requirements defined by IREN, a start-up will be founded to commercially exploit the innovations in the post-project phase.